Sherbrooke Park Advisers »

C4 Therapeutics shares owned by Sherbrooke Park Advisers

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Sherbrooke Park Advisers from 13F filings

Historical chart of Sherbrooke Park Advisers investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Sherbrooke Park Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Sherbrooke Park Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $63k 11k 5.65

More positions owned by Sherbrooke Park Advisers

Procter & Gamble Company (PG)
Cardinal Health (CAH)
Hologic (HOLX)
Costco Wholesale Corporation (COST)
Motorola Solutions Com New (MSI)
Owens Corning (OC)
Teradata Corporation (TDC)
Marathon Petroleum Corp (MPC)
Johnson & Johnson (JNJ)
Coca-Cola Company (KO)
Starbucks Corporation (SBUX)
Verisk Analytics (VRSK)
Jabil Circuit (JBL)
United Therapeutics Corporation (UTHR)
Molson Coors Beverage CL B (TAP)

View all positions for Sherbrooke Park Advisers

Top funds holding C4 Therapeutics

RA Capital Management
Daniel D. Thurber
Commodore Capital
Lynx1 Capital Management
T. Rowe Price Associates
Arrowpoint Asset Management
Vanguard Group
Point72 Asset Management
Soleus Capital Management
Balyasny Asset Management
Bank of America Corporation
Marshall Wace
Millennium Management
Citadel Advisors
Cubist Systematic Strategies

View all funds holding C4 Therapeutics